Mechanisms of motor neuron toxicity in Kennedy Disease
肯尼迪病运动神经元毒性机制
基本信息
- 批准号:8027315
- 负责人:
- 金额:$ 5.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-05 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:Abnormal CellAddressAdultAffectAllelesAndrogen ReceptorAnimalsBiochemicalCAG repeatCell CommunicationCellsCessation of lifeChronic DiseaseCodeCore FacilityDataDegenerative DisorderDevelopmentDiseaseEnvironmentExonsFunctional disorderGene MutationGene TargetingGenesGeneticGlutamineGoalsHormonalHormonesImpairmentKennedy SyndromeKnock-in MouseKnowledgeLaboratoriesLeadLengthLinkMediatingModelingModificationMolecularMotor Neuron DiseaseMotor NeuronsMusMuscleMuscle CellsMuscle FibersMuscle satellite cellMuscular AtrophyMyoblastsMyopathyNerveNerve DegenerationNervous system structureNeurodegenerative DisordersNeurogliaNeuronsOutcomePartner in relationshipPathogenesisPathologyPathway interactionsPatientsPlayProteinsPublic HealthReceptor GeneResearchResearch PersonnelRoleSeverity of illnessSiteSkeletal MuscleTestingToxic effectTransgenesUbiquitinWorkbasecell typedisease phenotypeeffective therapyhuman diseaseinsightmalemembermotor neuron degenerationmouse modelmulticatalytic endopeptidase complexmuscle regenerationmutantneuromuscularneuron lossneurotoxicitynew therapeutic targetnovel therapeutic interventionpolyglutamineprogramsprotein degradationreceptorreceptor functionrecombinaseregenerativeresponsespinal and bulbar muscular atrophyubiquitin ligase
项目摘要
Selective neuronal degeneration is a distinguishing feature of many adult onset neurodegenerative
disorders. Among these chronic diseases of the nervous system are ones caused by expansions of
CAG/glutamine tracts. Kennedy disease, a member of this group, is characterized by degeneration of lower
motor neurons due to an expanded CAG repeat in the first exon of the androgen receptor gene. Data from
several laboratories including our own demonstrate that the mutant androgen receptor protein misfolds,
aggregates and abnormally interacts with other proteins, leading to homone dependent lower motor neuron
degeneration and skeletal muscle atrophy. Despite significant advances in unraveling the disease basis,
pathways by which the mutant androgen receptor mediates selective motor neuron pathology remain
inadequately understood. Recent work has highlighted the importance of abnormal cell interactions and the
involvement of non-neuronal cells in the pathogenesis of certain polyglutamine and motor neuron diseases.
The objective of this proposal is to identifiy the pathways by which the expanded glutamine androgen
receptor causes selective neuronal loss. Our central hypothesis is that the mutant androgen receptor protein
exerts toxic effects on both lower motor neurons and the skeletal muscle cells they innervate that together
lead to selective neuronal pathology. This hypothesis is based on characterization of our recently developed
knock-in mouse model of Kennedy disease. We find that this model reproduces the neuromuscular and
systemic manifestations of this disorder. Furthermore, muscle pathology, which is accompanied by evidence
of a primary myopathy and by activation of the unfolded protein response, precedes motor neuron loss,
suggesting a role for non-cell autonomous toxicity. Biochemical, cellular and genetic approaches will be
employed to gain a better understanding of the mechanisms leading to skeletal muscle pathology (Aim 1),
the role of non-cell autonomous toxicity (Aim 2), and the contribution of the unfolded protein response to the
development of the disease phenotype (Aim 3). The relevance of the proposed studies to public health is
that they will provide new understanding of how proteins with expanded glutamine tracts cause
neurodegeneration. This work is also expected to reveal insights into mechanisms leading to selective lower
motor neuron dysfunction and death.
选择性神经元变性是许多成人发病的神经退行性疾病的显著特征
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW P LIEBERMAN其他文献
ANDREW P LIEBERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW P LIEBERMAN', 18)}}的其他基金
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration
尼曼-匹克 C 型神经变性的治疗靶点
- 批准号:
10907065 - 财政年份:2021
- 资助金额:
$ 5.83万 - 项目类别:
Mechanisms of neuromuscular degeneration in SBMA
SBMA 神经肌肉变性的机制
- 批准号:
10471367 - 财政年份:2021
- 资助金额:
$ 5.83万 - 项目类别:
Therapeutic targets for Niemann-Pick type C neurodegeneration
尼曼-皮克 C 型神经变性的治疗靶点
- 批准号:
10271742 - 财政年份:2021
- 资助金额:
$ 5.83万 - 项目类别:
Mechanisms of neuromuscular degeneration in SBMA
SBMA 神经肌肉变性的机制
- 批准号:
10290437 - 财政年份:2021
- 资助金额:
$ 5.83万 - 项目类别:
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration
尼曼-匹克 C 型神经变性的治疗靶点
- 批准号:
10468243 - 财政年份:2021
- 资助金额:
$ 5.83万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 5.83万 - 项目类别:
Research Grant